Skip to main content

Advertisement

ADVERTISEMENT

News

News
02/05/2021
Fresenius Kabi USA has expanded its ketorolac tromethamine injection recall to include nearly 1 million vials of a prescription-strength nonsteroidal anti-inflammatory drug used for the short-term relief of moderate to severe pain.
Fresenius Kabi USA has expanded its ketorolac tromethamine injection recall to include nearly 1 million vials of a prescription-strength nonsteroidal anti-inflammatory drug used for the short-term relief of moderate to severe pain.
Fresenius Kabi USA has expanded...
02/05/2021
Pharmacy Learning Network
News
01/28/2021
Whether individually or as part of a multidisciplinary team, pharmacist involvement in the management of patients with chronic pain is significant.
Whether individually or as part of a multidisciplinary team, pharmacist involvement in the management of patients with chronic pain is significant.
Whether individually or as part...
01/28/2021
Pharmacy Learning Network
News
01/28/2021
A Class II recall is active for an ophthalmic injection used to treat endophthalmitis, an infection of the tissues or fluid inside the eye.
A Class II recall is active for an ophthalmic injection used to treat endophthalmitis, an infection of the tissues or fluid inside the eye.
A Class II recall is active for...
01/28/2021
Pharmacy Learning Network

Advertisement

News
01/28/2021
American Health Packaging is recalling nitrofurantoin capsules because samples failed to meet dissolution specifications during testing.
American Health Packaging is recalling nitrofurantoin capsules because samples failed to meet dissolution specifications during testing.
American Health Packaging is...
01/28/2021
Pharmacy Learning Network
News
01/27/2021
“The [study] results can inform the design of implementation programs and tailored strategies to promote faster implementation of innovations in pharmacy,” researchers advised.
“The [study] results can inform the design of implementation programs and tailored strategies to promote faster implementation of innovations in pharmacy,” researchers advised.
“The [study] results can inform...
01/27/2021
Pharmacy Learning Network
News
01/25/2021
“Compared with the results of the survey published in 2004, educational and scholarly activities have expanded greatly,” researchers reported, “while administrative responsibilities of ICU pharmacists have remained consistently broad.”
“Compared with the results of the survey published in 2004, educational and scholarly activities have expanded greatly,” researchers reported, “while administrative responsibilities of ICU pharmacists have remained consistently broad.”
“Compared with the results of...
01/25/2021
Pharmacy Learning Network

Advertisement

News
01/21/2021
A Class II recall is active for a prescription medication used to help control blood sugar levels in people with type 2 diabetes.
A Class II recall is active for a prescription medication used to help control blood sugar levels in people with type 2 diabetes.
A Class II recall is active for...
01/21/2021
Pharmacy Learning Network
News
01/21/2021
Precision Dose Inc. is recalling more than 1 million unit dose cups of chlorhexidine gluconate oral rinse 0.12% because of deviations from Current Good Manufacturing Practice regulations.
Precision Dose Inc. is recalling more than 1 million unit dose cups of chlorhexidine gluconate oral rinse 0.12% because of deviations from Current Good Manufacturing Practice regulations.
Precision Dose Inc. is recalling...
01/21/2021
Pharmacy Learning Network
News
01/21/2021
Particulate matter discovered in multiple lots of oxycodone hydrochloride oral solution has prompted Genus Lifesciences Inc. to voluntarily recall more than two dozen lots of the pain medication.
Particulate matter discovered in multiple lots of oxycodone hydrochloride oral solution has prompted Genus Lifesciences Inc. to voluntarily recall more than two dozen lots of the pain medication.
Particulate matter discovered in...
01/21/2021
Pharmacy Learning Network

Advertisement

News
01/15/2021
SCA Pharmaceuticals is recalling more than 20,000 ketamine syringes because the syringe caps are potentially defective and could compromise sterility of the drug.
SCA Pharmaceuticals is recalling more than 20,000 ketamine syringes because the syringe caps are potentially defective and could compromise sterility of the drug.
SCA Pharmaceuticals is recalling...
01/15/2021
Pharmacy Learning Network